Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients
Viruses · 05.02.2023 · 15 (2) · 439
DOI: 10.3390/v15020439 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 05.02.2023. Verfasst von Ralph Tayyar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA. Hauptthemen laut MEDLINE: Chickenpox, Herpes Zoster, Varicella Zoster Virus Infection, Neoplasms. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Herpes simplex virus (HSV) and varicella zoster virus (VZV) are alpha herpesviruses that establish life-long latent infection in neuronal ganglia after primary infection. Periodic reactivation of these viruses results in recurrent infections that can have significant impact on patients’ quality of life. HSV commonly causes oral and genital mucocutaneous infections whereas VZV is responsible for varicella/chickenpox and herpes zoster/shingles, but cancer patients are at particularly higher risk of complications including disseminated and visceral infections due to impaired cell-mediated immunity. While diagnosis of more common HSV and/or VZV infections is frequently clinically based, immunocompromised hosts may have atypical skin presentation or visceral involvement. Thus, diagnostic confirmation using virus-specific tests such as polymerase chain reaction or immunohistochemical staining is crucial in some cases. Oral acyclovir, valacyclovir and famciclovir are usually used for mild to moderate infections and intravenous acyclovir is the drug of choice for severe or disseminated infections. Foscarnet can be used when acyclovir-resistance is confirmed or suspected. Pharmaceutical prophylaxis against HSV and/or VZV should be considered in high-risk cancers patients. Currently, there is no commercially available vaccine against HSV, but VZV vaccines are available to prevent varicella and zoster.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
ORCID-Profile: Ralph Tayyar
Zitieren
APA
Tayyar, R., & Ho, D. (2023). Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients. Viruses, 15(2), 439. https://doi.org/10.3390/v15020439
Vancouver
Tayyar R, Ho D. Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients. Viruses. 2023;15(2):439. doi:10.3390/v15020439
BibTeX
@article{Tayyar2023,
author = {Tayyar, Ralph and Ho, Dora},
title = {Herpes Simplex Virus and Varicella Zoster Virus Infections in Cancer Patients},
journal = {Viruses},
year = {2023},
volume = {15},
number = {2},
pages = {439},
doi = {10.3390/v15020439}
}
EUVIMED